Nearly 30% of ELBW infants with a normal HUS had either CP or a low MDI. Risk factors that are associated with this high rate of adverse outcomes include pneumothorax, prolonged exposure to mechanical ventilation, and educational and economic disadvantage. Improvements in pulmonary care to reduce duration of ventilation and avoid air leaks might improve neurodevelopmental outcome for ELBW infants.
This analysis suggests that the increasing survival of extremely low birth weight neonates since the late 1970s has not resulted in an increased rate of major developmental problems identifiable at 1 year of age.
Prematurity was associated with higher BP and reduced renal function that were detectable in adolescence. OWO and sex may modify the strength of these relationships.
SUMMARY
Outcomes were compared for 31 very‐low‐birthweight children recovered from chronic lung disease and 31 very‐low‐birthweight controls. All children had been free of major abnormalities on neonatal cranial ultrasonography. At 4 to 5 years of age, children were examined by a pediatrician and tested by a psychologist who administered the Wechsler Preschool and Primary Scale of Intelligence‐Revised. Despite similar medical outcomes, the children who had had neonatal chronic lung disease had lower Full‐scale IQs (median 83 vs 87) and Performance IQs (79 vs 90). Median Verbal IQ was similar in the two groups (85 vs.87). A higher proportion of children who had had chronic lung disease had Full‐scale IQ<70 (8/31 [26%] vs 1/31 [3%]) and Performance IQ<70 (8/31 [26%] vs 0/31). These effects persisted after adjustment for confounding factors.
RÉSUMÉ
Devenir a I'âge de 4 on 5 aits d'enfants ayant recupere apres une maladie pulmoiiaire chronique neonatale
Les devenirs ont eAté compares, pour 31 enfants de tres faible poids de naissance ayant recupere apres une affection pulmonaire chronique et 31 controles de tres faible poids de naissance.
L'échographie néonatale transcranienne n'avait révélé d'anomalies chez aucun des enfants. Les enfants furent examines a 4 ou 5 ans par un pediatre et testes a l'Echelle d'intelligence revisee de Weschler pour enfants d'âge prescolaire. En depit d'un devenir medical identique, les enfants avec affection pulmonaire neonatale chronique presentaient un QI plus faible a I'echelle globale (median de 83 contre 87) et de performance (79 vs 90). Le median du QI verbal etait semblable pour les deux groupes (85 vs 87). Une plus forte proportion d'enfants ayant presente une affection pulmonaire chronique avaient un QL 70 a ľ'echelle globale (8/31 [26%] vs 1/31 [3%]) et a I'echelle de performance (8/31 [26%] vs 0/31). Ces effets persistaient apres ajustement de facteurs annexes.
ZUSAMMENFASSUNG
Outcome im Alter von 4 bis 5 Jahren bet Kindern. die erne neonatale chronische Lungenerkrankung hatten
Per Outcome von 31 Kindern mit sehr niedrigem Geburtsgewicht, die eine chronische Lungenerkrankung hatten, wurde mit dem von 31 Kontrollkindern mit sehr niedrigem Geburtsgewicht verglichen. Alle Kinder hatten cin weitgehend unauffalliges neonatales Schadelsonogramm. Im Alter von 4 bis 5 Jahren wurden die Kinder von einem Kinderarzt untersucht und von einem Psychologen mit derWechsler Preschool and Primary Scale of Intelligence‐Revised getestet. Trotz eines ahnlichen medizinischen Outcomes hatten die Kinder mit neonataler chronischer Lungenerkrankung niedrigere Gesamt IQ Werte (Im Mittel 83 vs 87) und Handlungs‐IQs (79 vs 90). Der mittlere verbale IQ war in beiden Gruppen fast gleich (85 vs 87). Eine groBere Anzahl von Kindern, die eine chronische Lungenerkrankung gehabt haben, hatten einen Gesamt IQ<70 (8/31 [26%] vs 1/31 [3%]) und einen Handlungs‐IQ<70 (8/31 [26%] vs 0/31). Diese Befunde blieben auch nach Herausnahme unklarer Faktoren bestehen.
RESUMEN
Nivel alcanzado a la edad de 4 a 5 años en niños re...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.